Results 191 to 200 of about 102,405 (251)

Direct oral anticoagulants versus low-molecular-weight heparin for thromboprophylaxis in cancer-related surgeries: A meta-analysis of efficacy and safety outcomes. [PDF]

Am Heart J Plus
Mousavi A, Shojaei S, Dastjerdi P, Rahmati S, Izadpanahi K, Pishraft-Sabet H, Afshar EJ, Salehi K, Sabri M, Arbatan MN, Fallahtafti P, Wilbert A, Ambrosy AP, Syed MA, Iskander M, Hosseini K.   +15 more
europepmc   +1 more source

Efficacy and safety of low-molecular-weight heparin or rivaroxaban combined with immunotherapy and chemotherapy in the treatment of advanced nonsmall cell lung cancer: a prospective, randomized, controlled clinical study. [PDF]

Cancer Immunol Immunother
Zhang H, Li J, Yuan G, Huang S, Li X.
europepmc   +1 more source

Correction to “The Dynamic Evolution of Lipid Profiles Following Transjugular Intrahepatic Portosystemic Shunt in Patients With Liver Cirrhosis”

Portal Hypertension &Cirrhosis, EarlyView.
wiley   +1 more source

The Role of Extended Thromboprophylaxis With Low-Molecular-Weight Heparin Following Abdominopelvic Surgery for Cancer. [PDF]

Clin J Oncol Nurs
Adeoye L, Bannerman-Martin A.
europepmc   +1 more source

Analysis of the Application Value of Low Molecular Weight Heparin Combined with Heparin in Patients with Chorionic Bump in Early Pregnancy. [PDF]

Int J Womens Health
Peng XT, Cai ZH, Shen J, Zhu HY.
europepmc   +1 more source

Optimal Management of Bleeding and Thrombosis in Total Knee Arthroplasty: Tranexamic Acid With Acetylsalicylic Acid or Low-Molecular-Weight Heparin. [PDF]

Cureus
Uzunay Z, Satilmis AB, Cengiz T, Yalcin MN.   +3 more
europepmc   +1 more source

Efficacy and safety study of tranexamic acid combined with low-molecular-weight heparin and nadroparin calcium in postoperative application after joint replacement: a retrospective cohort study. [PDF]

BMC Musculoskelet Disord
Haibier A, Aierxiding S, Yusufu A, Lin H.   +3 more
europepmc   +1 more source

Giant cellulitis‐like Sweet's syndrome induced by gilteritinib

JDDG: Journal der Deutschen Dermatologischen Gesellschaft, EarlyView.
Juan de Luque‐Fernández, Irene Rivera‐Ruiz, Irene Suárez‐Vergne, Inmaculada Sánchez‐Ramírez, Manuel Galán‐Gutiérrez, Antonio José Vélez García‐Nieto   +5 more
wiley   +1 more source

Some of the next articles are maybe not open access.

Related searches:

Heparin and low-molecular-weight heparin

Thrombosis and Haemostasis, 2008
SummaryHeparin is one of the oldest biological medicines, and has an established place in the prevention and treatment of venous thrombosis. Low-molecular-weight heparins (LMWH) have been developed by several manufacturers and have advantages in terms of pharmacokinetics and convenience of administration.
Elaine Gray, Barbara Mulloy
exaly   +3 more sources